Two Sigma Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-40,600
| Closed | -$2.73M | – | 2779 |
|
|
2022
Q2 | $2.73M | Buy |
40,600
+26,600
| +190% | +$1.79M | 0.01% | 1056 |
|
|
2022
Q1 | $1.15M | Sell |
14,000
-12,300
| -47% | -$1.01M | ﹤0.01% | 1566 |
|
|
2021
Q4 | $3.86M | Sell |
26,300
-14,400
| -35% | -$2.11M | 0.01% | 888 |
|
|
2021
Q3 | $7.2M | Sell |
40,700
-28,300
| -41% | -$5.01M | 0.02% | 626 |
|
|
2021
Q2 | $11.1M | Sell |
69,000
-63,600
| -48% | -$10.3M | 0.03% | 526 |
|
|
2021
Q1 | $22.7M | Sell |
132,600
-2,000
| -1% | -$343K | 0.06% | 332 |
|
|
2020
Q4 | $29.6M | Buy |
134,600
+49,000
| +57% | +$10.8M | 0.08% | 255 |
|
|
2020
Q3 | $14.2M | Sell |
85,600
-32,200
| -27% | -$5.35M | 0.04% | 422 |
|
|
2020
Q2 | $13.4M | Buy |
117,800
+8,300
| +8% | +$948K | 0.04% | 444 |
|
|
2020
Q1 | $8.42M | Sell |
109,500
-80,900
| -42% | -$6.22M | 0.03% | 539 |
|
|
2019
Q4 | $24.5M | Buy |
190,400
+2,800
| +1% | +$361K | 0.06% | 330 |
|
|
2019
Q3 | $14.6M | Buy |
187,600
+20,700
| +12% | +$1.61M | 0.04% | 450 |
|
|
2019
Q2 | $17.2M | Buy |
166,900
+60,800
| +57% | +$6.26M | 0.04% | 444 |
|
|
2019
Q1 | $7.78M | Buy |
106,100
+18,500
| +21% | +$1.36M | 0.02% | 686 |
|
|
2018
Q4 | $3.72M | Buy |
87,600
+7,000
| +9% | +$297K | 0.01% | 912 |
|
|
2018
Q3 | $3.8M | Buy |
80,600
+54,600
| +210% | +$2.57M | 0.01% | 932 |
|
|
2018
Q2 | $1.28M | Buy |
+26,000
| New | +$1.28M | ﹤0.01% | 1502 |
|